Download Course Program

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Prostate cancer screening wikipedia , lookup

Transcript
PROSTATE CANCER – BACK TO FUTURE
WAKE FOREST UNIVERSITY – THIRD ANNUAL SYMPOSIUM
APRIL 15 & 16, 2016
Day 1 – Friday, April 15, 2016
Introduction
7:50 – 7:55 AM
Welcome Address
Anthony Atala,
7:55 – 8:00 AM
Overview of the Symposium
K. C. Balaji
Session 1:
8:00 AM – 10:10 AM
Category – Metastatic Prostate Cancer
Moderators:
Christopher Thomas
and Paul Rennie
8:00 – 8:30
Chemotherapy; First or Last in Metastatic
Prostate Cancer?
Christopher Sweeney
8:30 – 9:00
Advances in Immunotherapy in Prostate
Cancer
Purnima Dubey
9:00 – 9:30
PIVOT Study- An Analysis
Timothy Wilt
9:30 – 9:50
Should We Classify Metastatic Prostate
Cancer; Nodes, Bones or Visceral
Metastasis
K. C. Balaji
9:50 – 10:10
Panel Discussion
10:10 – 10:30 -
BREAK
Session II:
10:30 AM – 12:10 PM
Category – Resistance in Castration
Resistant Prostate Cancer
Moderators: Andrew
Armstrong and
Christopher Sweeney
10:30 – 11:00
CTC as Biomarkers to Study Resistance
to Treatment in CRPC
Christopher Thomas
11:00 – 11:30
Strategies to Overcome Resistance to
Antiandrogens to Prostate Cancer
Paul Rennie
11:30 – 11:50
Role of Surgery or Radiation in Patients
with Oligometastatic Prostate Cancer
Rhonda Bitting
11:50 – 12:10
Panel Discussion
12:10 – 1:00
LUNCH
Session III:
1:00 PM – 3:10 PM
Category – Novel Agents in Prostate
Cancer
Moderators: Rhonda
Bitting and Purnima
Dubey
1:00 – 1:30
Bromodomain Inhibitors in Cancer
Irfan Asangani
1:30 – 2:00
Targeting Ubiquitination Signaling for
Prostate Cancer
Hui-Kuan Lin
2:00 – 2:30
Targeting Neuroendocrine Differentiation
in Prostate Cancer
Andrew Armstrong
2:30 – 2:40
CDC 25: Potential Target in Prostate
Cancer
Sittadjody
Sivanandane
2:40 – 3:10
Panel Discussion
3:10 – 3:30
BREAK
Session IV:
3:30 PM – 5:30 PM
Category – Imaging as Biomarker in
Prostate Cancer
Moderators: Ashok
Hemal and Bart
Frizzell
3:30 – 4:00
Prostate Imaging, Reporting, and Data
System (PIRADS); An Update
Rafel Tappouni
4:00 – 4:30
MRI US Fusion in Diagnosis of High
Risks Prostate Cancer
Pooja Doshi
4:30 – 5:00
Multiparametric Ultrasound in Diagnosis
of Prostate Cancer
Daniel Rukstalis
5:00 – 5:30
Role of Multiparametric MRI in Active
Surveillance for Prostate Cancer
Keyanoosh
Hosseinzadeh
Day 2 – Saturday, April
16, 2016
7:55 – 8:00 AM
Welcome back
K. C. Balaji
Session V:
8:00 – 10:10 AM
Category – Biostatistics for Prostate
Cancer
Moderator: Ronald
Davis
08.00 – 08:30
Development and Opportunities for
Nomograms in Prostate Cancer
Michael Kattan
08:30 – 09:00
Incorporating Probabilities in Surgical
Management of Prostate Cancer
Ashok Hemal
09:00 – 09:30
Cancer Informatics Platforms for Future
Analytics & Research
Umit Topaloglu
09.30 – 09:50
Panel Discussion
09.50 – 10.10
BREAK
Session VI:
10.10 AM – 12:00 PM
Category – Prognostication in Prostate
Cancer
Moderators: Michael
Kattan and Ashok
Hemal
10.10 – 10.30
Genetic Predictors of Arachidonic Acid
Metabolism in Prostate Cancer.
Tao Cui
10:30 – 11.00
Gene Expression Signatures in
Management of Prostate Cancer
Ronald Davis
11.00 – 11.20
Study of Visceral Metastases; a Marker of
Poor Prognosis in Prostate Cancer
Michael Rothberg
11.20 – 11.50
Serum PSA as Predictor of Response to
Adjuvant Radiotherapy in Prostate Cancer
11.50 - 12.00
Panel discussion and closing remarks
BOXED LUNCHES
Bart Frizzell